Enzyme Inhibition
Also known as: enzyme blocking, enzymatic inhibition, enzyme suppression
Enzyme Inhibition The process of blocking or reducing an enzyme's catalytic activity through the binding of an inhibitor molecule. Enzyme inhibition is a fundamental regulatory mechanism in biochemistry and a primary strategy for developing therapeutic agents including many peptide drugs.
Last updated: February 1, 2026
What is Enzyme Inhibition?
Enzyme inhibition refers to the reduction or complete blocking of an enzyme’s catalytic activity by a molecule called an inhibitor. Enzymes are biological catalysts essential for virtually all cellular processes, and their activity must be carefully regulated. Inhibition can be reversible or irreversible and occurs through various mechanisms depending on how the inhibitor interacts with the enzyme.
Types of Enzyme Inhibition
Several mechanisms of inhibition exist:
- Competitive inhibition: Inhibitor competes with substrate for the active site
- Non-competitive inhibition: Inhibitor binds at an allosteric site, reducing catalytic efficiency
- Uncompetitive inhibition: Inhibitor binds only to the enzyme-substrate complex
- Mixed inhibition: Inhibitor affects both substrate binding and catalysis
- Irreversible inhibition: Inhibitor permanently inactivates the enzyme through covalent modification
Each type has distinct kinetic properties and therapeutic applications.
Enzyme Inhibitors in Peptide Therapeutics
Peptides make excellent enzyme inhibitors due to their specificity and biocompatibility:
- ACE inhibitors: Peptide-based inhibitors of angiotensin-converting enzyme for hypertension
- DPP-4 inhibitors: Target dipeptidyl peptidase-4 to enhance incretin hormones in diabetes
- HIV protease inhibitors: Peptide mimetics that block viral protease essential for replication
- Coagulation cascade inhibitors: Peptides targeting thrombin and other clotting factors
Natural peptide inhibitors also exist, such as serpins that inhibit serine proteases.
Therapeutic Significance
Enzyme inhibition is one of the most successful strategies in drug development:
- Disease modification: Many diseases involve overactive enzymes
- Pathway regulation: Blocking one enzyme can modulate entire metabolic pathways
- Biomarker applications: Enzyme inhibition can be measured to monitor treatment
Design Considerations
Developing peptide enzyme inhibitors requires attention to:
- Selectivity: Avoiding inhibition of related enzymes
- Potency: Achieving sufficient binding affinity
- Stability: Ensuring the peptide survives in biological fluids
- Reversibility: Determining if permanent or temporary inhibition is desired
Related Concepts
- Active site: The catalytic region of an enzyme
- Inhibition constant (Ki): Quantitative measure of inhibitor potency
- Transition state analogs: Inhibitors mimicking the reaction intermediate
Related Terms
Disclaimer: This glossary entry is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for medical questions.